Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Joe E. who wrote (2508)	10/27/1997 4:47:00 PM
From: Joe E.	Read Replies (1) \| Respond to of 6136

Re my post last night: "Fearless suggestion for the week ahead: Go ahead and buy this week if you get a chance to do so at 44 or better, as you won't likely get another. At 44 I calculate AGPH to be 25% undervalued, or so. No refunds are offered if this suggestion turns out to be stupid. " This could not quite be done today, and probably (given the mood of the market) everyone will be too scared to do it tomorrow. Events in Asia will have essentially no impact on AGPH unless they trigger a world-wide depression a la 1930, which is pretty darn unlikely. 44 is still a good price, but 42 could be available this week too, given how the market is moving. I still like covered calls, and I expect option risk premiums to expand tomorrow. Still not offering refunds if this turns out to be dumb advice.